Clinical trial / 2020
Niacin supplementation boosted NAD+ levels, increased muscle strength, and reduced liver fat in adult-onset mitochondrial myopathy patients.
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
- Study type
- Intervention trial with matched controls
- Who was studied
- Adult-onset mitochondrial myopathy patients and matched controls
- What was measured
- Blood and muscle NAD+ levels, muscle strength, mitochondrial biogenesis, muscle metabolome, liver fat, and safety markers
THE PAPER
Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.
Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, Hakkarainen A, Kuula J, Heinonen U, Schmidt MS, Haimilahti K, Piirilä P, Lundbom N, Taskinen MR, Brenner C, Velagapudi V, Pietiläinen KH, Suomalainen A. Cell Metab, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.